SCM
STRO icon

Suvretta Capital Management’s Sutro Biopharma STRO Stock Holding History

Suvretta Capital Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-648,832
Closed -$5.63M – 106
2025
Q3 		$5.63M Hold
648,832
– – 0.14% 67
2025
Q2 		$4.63M Sell
648,832
-97,418
-13% -$797K 0.14% 64
2025
Q1 		$4.86M Hold
746,250
– – 0.18% 63
2024
Q4 		$13.7M Buy
746,250
+27,500
+4% +$840K 0.47% 51
2024
Q3 		$24.9M Sell
718,750
-52,119
-7% -$2.04M 0.8% 40
2024
Q2 		$22.6M Buy
770,869
+193,050
+33% +$7.63M 0.83% 39
2024
Q1 		$32.6M Hold
577,819
– – 1.21% 29
2023
Q4 		$24.8M Sell
577,819
-10,550
-2% -$335K 1.12% 31
2023
Q3 		$20.4M Hold
588,369
– – 1.1% 29
2023
Q2 		$27.4M Buy
588,369
+19,460
+3% +$969K 1.46% 24
2023
Q1 		$26.3M Buy
568,909
+12,399
+2% +$787K 1.11% 31
2022
Q4 		$45M Buy
556,510
+54,510
+11% +$3.79M 1.89% 23
2022
Q3 		$27.9M Buy
502,000
+37,500
+8% +$2.22M 1.16% 34
2022
Q2 		$24.2M Buy
464,500
+91,260
+24% +$5.1M 0.92% 38
2022
Q1 		$30.7M Buy
373,240
+129,460
+53% +$12.3M 0.94% 37
2021
Q4 		$36.3M Buy
243,780
+20,410
+9% +$3.66M 0.7% 38
2021
Q3 		$42.2M Buy
223,370
+51,832
+30% +$9.86M 0.71% 39
2021
Q2 		$31.9M Buy
171,538
+43,040
+33% +$8.42M 0.48% 48
2021
Q1 		$29.2M Buy
128,498
+24,957
+24% +$5.92M 0.43% 50
2020
Q4 		$22.5M Sell
103,541
-13,476
-12% -$2.23M 0.32% 52
2020
Q3 		$11.8M Buy
117,017
+26,737
+30% +$2.53M 0.21% 49
2020
Q2 		$7.01M Buy
90,280
+82,180
+1,015% +$7.89M 0.15% 54
2020
Q1 		$826K Buy
+8,100
New +$851K 0.02% 54

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Suvretta Capital Management's STRO Position: Q4 2025 in Review

Suvretta Capital Management sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 648,832 shares — an estimated $5.63M sold.

Suvretta Capital Management first reported a position in STRO in Q1 2020 and held it in 23 quarters. The position peaked at $45M in Q4 2022. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • Suvretta Capital Management reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • Suvretta Capital Management sold 648,832 Sutro Biopharma shares in Q4 2025, an estimated $5.63M.
  • Suvretta Capital Management first reported a position in Sutro Biopharma in Q1 2020 and held it in 23 quarters.
  • Suvretta Capital Management's Sutro Biopharma position peaked at $45M in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Suvretta Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.